Didriksen, Maria http://orcid.org/0000-0002-4856-496X
Nawaz, Muhammad Sulaman http://orcid.org/0000-0002-5576-9007
Dowsett, Joseph http://orcid.org/0000-0001-5381-2633
Bell, Steven http://orcid.org/0000-0001-6774-3149
Erikstrup, Christian http://orcid.org/0000-0001-6551-6647
Pedersen, Ole B. http://orcid.org/0000-0003-2312-5976
Sørensen, Erik
Jennum, Poul J.
Burgdorf, Kristoffer S.
Burchell, Brendan http://orcid.org/0000-0002-8243-937X
Butterworth, Adam S. http://orcid.org/0000-0002-6915-9015
Soranzo, Nicole
Rye, David B.
Trotti, Lynn Marie
Saini, Prabhjyot
Stefansdottir, Lilja
Magnusson, Sigurdur H.
Thorleifsson, Gudmar
Sigmundsson, Thordur
Sigurdsson, Albert P.
Van Den Hurk, Katja
Quee, Franke
Tanck, Michael W. T. http://orcid.org/0000-0001-9828-4459
Ouwehand, Willem H. http://orcid.org/0000-0002-7744-1790
Roberts, David J.
Earley, Eric J. http://orcid.org/0000-0001-6576-1319
Busch, Michael P. http://orcid.org/0000-0002-1446-125X
Mast, Alan E.
Page, Grier P. http://orcid.org/0000-0003-2582-3786
Danesh, John
Di Angelantonio, Emanuele
Stefansson, Hreinn http://orcid.org/0000-0002-9331-6666
Ullum, Henrik
Stefansson, Kari http://orcid.org/0000-0003-1676-864X
Funding for this research was provided by:
British Heart Foundation (RG/13/13/30194)
Scottish Government
Cancer Research UK
Article History
Received: 26 May 2020
Accepted: 21 October 2020
First Online: 25 November 2020
Competing interests
: A.E.M. received funding from Novo Nordisk. M.S.N., L.S., S.H.M., G.T., H.S., and K.S. are employees of deCODE genetics/Amgen. J.D reports grants, personal fees and non-financial support from Merck Sharp & Dohme (MSD), grants, personal fees and non-financial support from Novartis, grants from Pfizer and grants from AstraZeneca outside the submitted work. John Danesh sits on the International Cardiovascular and Metabolic Advisory Board for Novartis (since 2010); the Steering Committee of UK Biobank (since 2011); the MRC International Advisory Group (ING) member, London (since 2013); the MRC High Throughput Science ‘Omics Panel Member, London (since 2013); the Scientific Advisory Committee for Sanofi (since 2013); the International Cardiovascular and Metabolism Research and Development Portfolio Committee for Novartis; and the Astra Zeneca Genomics Advisory Board (2018). A.B reports grants outside of this work from AstraZeneca, Biogen, BioMarin, Bioverativ, Merck, Novartis and Pfizer and personal fees from Novartis. The remaining authors have disclosed no conflicts of interest.